|
|
|
Insider
Information: |
Li Bin |
Relationship: |
10% Owner |
City: |
Hong Kong |
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
3,825,744 |
|
Indirect Shares
|
7,088,903 |
|
|
Direct
Value |
$661,954 |
|
|
Indirect Value
|
$70,889 |
|
|
Total
Shares |
10,914,647 |
|
|
Total
Value |
$732,843 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Sciclone Pharmaceuticals Inc |
SCLN |
|
2016-02-22 |
678,077 |
|
0 |
Premium* |
|
Sorrento Therapeutics Inc |
SRNE |
10% Owner |
|
0 |
2018-02-07 |
7,088,903 |
Premium* |
|
Biocept Inc |
BIOC |
10% Owner |
2017-08-09 |
3,147,667 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SCLN |
Sciclone Pharmaceuticals ... |
|
|
2016-02-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
678,077 |
|
- |
|
SRNE |
Sorrento Therapeutics Inc |
10% Owner |
|
2016-07-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,082,536 |
|
- |
|
BIOC |
Biocept Inc |
10% Owner |
|
2016-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,681,000 |
|
- |
|
BIOC |
Biocept Inc |
10% Owner |
|
2017-08-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,147,667 |
|
- |
|
SRNE |
Sorrento Therapeutics Inc |
10% Owner |
|
2017-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
5,082,536 |
3,243,242 |
0 |
- |
|
BIOC |
Biocept Inc |
10% Owner |
|
2017-01-17 |
4 |
D |
$1.10 |
$964,039 |
D/D |
(876,399) |
804,601 |
0 |
- |
|
BIOC |
Biocept Inc |
10% Owner |
|
2017-01-18 |
4 |
D |
$1.10 |
$604,679 |
D/D |
(549,708) |
254,893 |
0 |
- |
|
BIOC |
Biocept Inc |
10% Owner |
|
2017-01-19 |
4 |
D |
$1.10 |
$280,382 |
D/D |
(254,893) |
0 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
10% Owner |
|
2017-04-19 |
4 |
B |
$2.00 |
$1,100,000 |
I/I |
550,000 |
1,991,441 |
1.5 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
10% Owner |
|
2018-01-29 |
4 |
S |
$7.61 |
$569,286 |
I/I |
(74,844) |
1,482,037 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
10% Owner |
|
2018-01-30 |
4 |
S |
$7.65 |
$1,799,578 |
I/I |
(235,156) |
1,425,000 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
10% Owner |
|
2018-02-05 |
4 |
S |
$8.00 |
$566,037 |
I/I |
(70,721) |
1,408,027 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
10% Owner |
|
2018-02-06 |
4 |
S |
$6.75 |
$3,464,259 |
I/I |
(512,912) |
1,478,529 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
10% Owner |
|
2018-02-07 |
4 |
S |
$7.19 |
$1,077,975 |
I/I |
(150,000) |
1,328,529 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|